« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 12, Issue 2
, Pages
204-216
, February 2006
Pretransplantation Consolidation Chemotherapy Decreases Leukemia Relapse after Autologous Blood and Bone Marrow Transplants for Acute Myelogenous Leukemia in First Remission
-
Cumulative incidences of TRM (A) and relapse (B) after autologous bone marrow (BM) or PBSC transplantation for AML in first CR by pretransplantation cytarabine consolidation therapy.
Cumulative incidences of TRM (A) and relapse (B) after autologous bone marrow (BM) or PBSC transplantation for AML in first CR by pretransplantation cytarabine consolidation therapy.
-
Adjusted probabilities of LFS (A) and overall survival (B) after autologous bone marrow (BM) or PBSC transplantation for AML in first CR by cytarabine pretransplantation consolidation therapy.
Adjusted probabilities of LFS (A) and overall survival (B) after autologous bone marrow (BM) or PBSC transplantation for AML in first CR by cytarabine pretransplantation consolidation therapy.
PII: S1083-8791(05)00683-X
doi: 10.1016/j.bbmt.2005.10.013
© 2006 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 12, Issue 2
, Pages
204-216
, February 2006
